Ming‐Fong Lin

5.1k total citations
100 papers, 4.1k citations indexed

About

Ming‐Fong Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ming‐Fong Lin has authored 100 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 44 papers in Pulmonary and Respiratory Medicine and 24 papers in Oncology. Recurrent topics in Ming‐Fong Lin's work include Prostate Cancer Treatment and Research (41 papers), Ubiquitin and proteasome pathways (15 papers) and Estrogen and related hormone effects (11 papers). Ming‐Fong Lin is often cited by papers focused on Prostate Cancer Treatment and Research (41 papers), Ubiquitin and proteasome pathways (15 papers) and Estrogen and related hormone effects (11 papers). Ming‐Fong Lin collaborates with scholars based in United States, Taiwan and Japan. Ming‐Fong Lin's co-authors include Surinder K. Batra, Ta‐Chun Yuan, Ming‐Shyue Lee, Suresh Veeramani, Dev Karan, Chawnshang Chang, Fen-Fen Lin, Sonny L. Johansson, Shuyuan Yeh and Hong‐Yo Kang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Ming‐Fong Lin

99 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming‐Fong Lin United States 37 2.5k 1.6k 938 748 567 100 4.1k
Adrie van Bokhoven United States 35 2.5k 1.0× 1.6k 1.0× 992 1.1× 1.1k 1.4× 356 0.6× 74 4.6k
Daniel Gioeli United States 30 2.2k 0.9× 1.5k 0.9× 780 0.8× 580 0.8× 725 1.3× 69 3.6k
Amina Zoubeidi Canada 43 3.0k 1.2× 2.4k 1.5× 1.6k 1.7× 1.3k 1.8× 457 0.8× 126 5.0k
Stefano Pepe Italy 45 2.6k 1.0× 1.1k 0.7× 2.5k 2.7× 647 0.9× 366 0.6× 130 5.3k
Igor Vivanco United States 20 5.0k 2.0× 1.3k 0.8× 2.0k 2.1× 1.3k 1.7× 362 0.6× 28 7.0k
Donald Ogilvie United Kingdom 31 2.6k 1.0× 625 0.4× 1.3k 1.4× 501 0.7× 859 1.5× 82 4.5k
Sunmin Lee United States 30 2.7k 1.1× 741 0.5× 724 0.8× 1.3k 1.7× 283 0.5× 63 4.3k
M. E. Harper United Kingdom 28 1.7k 0.7× 1.6k 1.0× 1.9k 2.0× 570 0.8× 707 1.2× 66 4.2k
Yong Wen United States 16 1.9k 0.8× 519 0.3× 1.0k 1.1× 481 0.6× 344 0.6× 23 2.9k
Francesca Pentimalli Italy 38 2.3k 0.9× 429 0.3× 1.1k 1.1× 922 1.2× 444 0.8× 120 3.8k

Countries citing papers authored by Ming‐Fong Lin

Since Specialization
Citations

This map shows the geographic impact of Ming‐Fong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Fong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Fong Lin more than expected).

Fields of papers citing papers by Ming‐Fong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Fong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Fong Lin. The network helps show where Ming‐Fong Lin may publish in the future.

Co-authorship network of co-authors of Ming‐Fong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Fong Lin. A scholar is included among the top collaborators of Ming‐Fong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Fong Lin. Ming‐Fong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Dannah, Matthew A. Ingersoll, Yu‐Wei Chou, et al.. (2022). Dynamics of antioxidant heme oxygenase-1 and pro-oxidant p66Shc in promoting advanced prostate cancer progression. Free Radical Biology and Medicine. 193(Pt 1). 274–291. 8 indexed citations
2.
Al‐Masoudi, Najim A., et al.. (2020). A novel pregnene analogs: synthesis, cytotoxicity on prostate cancer of PC-3 and LNCPa-AI cells and in silico molecular docking study. Molecular Diversity. 25(2). 661–671. 7 indexed citations
3.
Ingersoll, Matthew A., Jamie S. Lin, Ta‐Chun Yuan, et al.. (2018). p66Shc regulates migration of castration-resistant prostate cancer cells. Cellular Signalling. 46. 1–14. 19 indexed citations
4.
Miller, Dannah, Cherng-Chyi Tzeng, Evan T. Keller, et al.. (2018). Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer. Cancer Letters. 436. 96–108. 6 indexed citations
5.
Chen, Linjie, Dennis W. Wolff, Yan Xie, Ming‐Fong Lin, & Yaping Tu. (2017). Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5. BMC Cancer. 17(1). 179–179. 14 indexed citations
6.
Muniyan, Sakthivel, Nagendra K. Chaturvedi, Jennifer B. Dwyer, et al.. (2013). Human Prostatic Acid Phosphatase: Structure, Function and Regulation. International Journal of Molecular Sciences. 14(5). 10438–10464. 68 indexed citations
7.
Tung, Yu‐Tang, Hsiao‐Ling Chen, Chih‐Ching Yen, et al.. (2013). Bovine lactoferrin inhibits lung cancer growth through suppression of both inflammation and expression of vascular endothelial growth factor. Journal of Dairy Science. 96(4). 2095–2106. 84 indexed citations
8.
Muniyan, Sakthivel, et al.. (2013). Androgens Upregulate Cdc25C Protein by Inhibiting Its Proteasomal and Lysosomal Degradation Pathways. PLoS ONE. 8(4). e61934–e61934. 17 indexed citations
9.
Chaturvedi, Nagendra K., Fen-Fen Lin, Dharam Kaushik, et al.. (2011). Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells. Cancer Letters. 311(2). 177–186. 32 indexed citations
10.
Wolff, Dennis W., Yan Xie, Caishu Deng, et al.. (2011). Epigenetic repression of regulator of G‐protein signaling 2 promotes androgen‐independent prostate cancer cell growth. International Journal of Cancer. 130(7). 1521–1531. 44 indexed citations
11.
Rajendran, Mythilypriya, Paul G. Thomes, Li Zhang, Suresh Veeramani, & Ming‐Fong Lin. (2010). p66Shc—a longevity redox protein in human prostate cancer progression and metastasis. Cancer and Metastasis Reviews. 29(1). 207–222. 42 indexed citations
12.
Yuan, Ta‐Chun, Suresh Veeramani, & Ming‐Fong Lin. (2007). Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocrine Related Cancer. 14(3). 531–547. 179 indexed citations
13.
Mimeault, Murielle, Ganesh Venkatraman, Sonny L. Johansson, et al.. (2006). Novel combination therapy against metastatic and androgen‐independent prostate cancer by using gefitinib, tamoxifen and etoposide. International Journal of Cancer. 120(1). 160–169. 28 indexed citations
14.
Stewart, LaMonica V., et al.. (2005). Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 97(1-2). 37–46. 12 indexed citations
15.
Karan, Dev, Sonny L. Johansson, Ajay P. Singh, et al.. (2003). Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochemical and Biophysical Research Communications. 305(3). 598–604. 60 indexed citations
16.
Zelivianski, Stanislav, Ming‐Shyue Lee, R. Taylor, et al.. (2003). ERK inhibitor PD98059 enhances docetaxel‐induced apoptosis of androgen‐independent human prostate cancer cells. International Journal of Cancer. 107(3). 478–485. 118 indexed citations
17.
Karan, Dev, Ming‐Fong Lin, Sonny L. Johansson, & Surinder K. Batra. (2002). Current status of the molecular genetics of human prostatic adenocarcinomas. International Journal of Cancer. 103(3). 285–293. 62 indexed citations
18.
Lin, Ming‐Fong, et al.. (2001). PROTEIN KINASE C PATHWAY IS INVOLVED IN REGULATING THE SECRETION OF PROSTATIC ACID PHOSPHATASE IN HUMAN PROSTATE CANCER CELLS. Cell Biology International. 25(11). 1139–1148. 5 indexed citations
19.
Karan, Dev, Sonny L. Johansson, Ming‐Fong Lin, & Surinder K. Batra. (2001). Expression of tumor-associated glycoprotein-72 (TAG-72) antigen in human prostatic adenocarcinomas. Oncology Reports. 8(5). 1123–6. 4 indexed citations
20.
Lin, Ming‐Fong & Renee Garcia‐Arenas. (1994). Effect of cell density on androgen regulation of the mRNA level of human prostatic acid phosphatase. Molecular and Cellular Endocrinology. 99(2). R21–R24. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adrie van Bokhoven Breakdown of academic impact, for papers by Daniel Gioeli Breakdown of academic impact, for papers by Amina Zoubeidi Breakdown of academic impact, for papers by Stefano Pepe Breakdown of academic impact, for papers by Igor Vivanco Breakdown of academic impact, for papers by Donald Ogilvie Breakdown of academic impact, for papers by Sunmin Lee Breakdown of academic impact, for papers by M. E. Harper Breakdown of academic impact, for papers by Yong Wen Breakdown of academic impact, for papers by Francesca Pentimalli
Rankless by CCL
2026